A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4
Clinical trial NCT05522517 · COMPLETED
Trial details
- NCT number
- NCT05522517
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-22
- Primary completion
- 2022-11-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.